Cargando…
EGFR Mutations in Head and Neck Squamous Cell Carcinoma
EGFR is a prototypical receptor tyrosine kinase that is overexpressed in multiple cancers including head and neck squamous cell carcinoma (HNSCC). The standard of care for HNSCC remains largely unchanged despite decades of research. While EGFR blockade is an attractive target in HNSCC patients and a...
Autores principales: | Nair, Sindhu, Bonner, James A., Bredel, Markus |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8999014/ https://www.ncbi.nlm.nih.gov/pubmed/35409179 http://dx.doi.org/10.3390/ijms23073818 |
Ejemplares similares
-
Novel EGFR ectodomain mutations associated with ligand-independent activation and cetuximab resistance in head and neck cancer
por: Nair, Sindhu, et al.
Publicado: (2020) -
An ErbB Lineage Co-Regulon Harbors Potentially Co-Druggable Targets for Multimodal Precision Therapy in Head and Neck Squamous Cell Carcinoma
por: Bredel, Markus, et al.
Publicado: (2022) -
Study of EGFR mutations in head and neck squamous cell carcinomas
por: Kaur, Gurpreet, et al.
Publicado: (2021) -
Prognostic and predictive value of EGFR in head and neck squamous cell carcinoma
por: Bossi, Paolo, et al.
Publicado: (2016) -
Tyrosine kinase domain mutations of EGFR gene in head and neck squamous cell carcinoma
por: Vatte, Chittibabu, et al.
Publicado: (2017)